McKesson announces voluntary takeover offer to acquire Celesio

SAN FRANCISCO — McKesson on Thursday announced that the company has launched the voluntary public takeover offer for the outstanding shares of Celesio through its indirect, wholly-owned subsidiary Dragonfly in connection with the announcement on Oct. 24 of McKesson’s agreement to acquire Celesio.

The publication of the offer document for the takeover offer has been approved by the Bundesanstalt für Finanzdienstleistungsaufsicht and is now available on GlobalHealthcareLeader.com in German and in an English translation. 

Celesio shareholders can now accept the takeover offer and tender their shares in Celesio at the offer price of 23 Euros per share ($31.29 per share). The acceptance period will end on Jan. 9.